Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions

Journal of Neurochemistry
Utako NagaokaNobuyuki Nukina

Abstract

Huntington's disease is a progressive neurodegenerative disorder that is associated with a CAG repeat expansion in the gene encoding huntingtin. We found that a 60-kDa protein was increased in Neuro2a cells expressing the N-terminal portion of huntingtin with expanded polyglutamine. We purified this protein, and, using mass spectrometry, identified it as p62, an ubiquitin-associated domain-containing protein. A specific p62 antibody stained the ubiquitylated polyQ inclusions in expanded polyglutamine-expressing cells, as well as in the brain of the huntingtin exon 1 transgenic mice. Furthermore, the level of p62 protein and mRNA was increased in expanded polyglutamine-expressing cells. We also found that p62 formed aggresome-like inclusions when p62 was increased in normal Neuro2a cells by a proteasome inhibitor. Knock-down of p62 does not affect the formation of aggresomes or polyglutamine inclusions, suggesting that p62 is recruited to the aggresome or inclusions secondary to their formation. These results suggest that p62 may play important roles as a responsive protein to a polyglutamine-induced stress rather than as a cross-linker between ubiquitylated proteins.

References

May 22, 1998·Journal of Neuropathology and Experimental Neurology·J P Vonsattel, M DiFiglia
Dec 29, 1998·The Journal of Cell Biology·J A JohnstonR R Kopito
Jun 22, 1999·The Journal of Biological Chemistry·R A RachubinskiJ P Capone
Jun 9, 2000·Annual Review of Neuroscience·H Y Zoghbi, H T Orr
Feb 13, 2001·Biochemical and Biophysical Research Communications·E KuusistoA Salminen
Jan 12, 2002·The American Journal of Pathology·Kurt ZatloukalHelmut Denk
Feb 20, 2002·FEBS Letters·Thangiah Geetha, Marie W Wooten
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guangchao SuiYang Shi
Jun 11, 2002·Methods : a Companion to Methods in Enzymology·Sayda M ElbashirThomas Tuschl
Sep 13, 2002·The Journal of Biological Chemistry·Zhi-Liang WuDonna Bozyczko-Coyne
Jul 15, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kathryn M DonaldsonClaudio A P Joazeiro
Jul 16, 2003·Cell·Benoit I Giasson, Virginia M-Y Lee
Sep 10, 2003·Neuroreport·Evgeny A Zemskov, Nobuyuki Nukina

❮ Previous
Next ❯

Citations

Mar 11, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Motomasa TanakaNobuyuki Nukina
Sep 10, 2011·Journal of Neural Transmission·Bokyung ParkYoung J Oh
Feb 5, 2010·Apoptosis : an International Journal on Programmed Cell Death·Qian Huang, Maria E Figueiredo-Pereira
Dec 11, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Bruce J BrewGilles Guillemin
Mar 23, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Arshed NazmiAnirban Basu
Jan 14, 2011·The Journal of Biological Chemistry·Edith KarioAmi Navon
Mar 13, 2009·The Journal of Biological Chemistry·Peter O BauerNobuyuki Nukina
Jun 22, 2010·Antioxidants & Redox Signaling·Melissa NassifClaudio Hetz
May 27, 2008·Human Molecular Genetics·Esther S P WongKah-Leong Lim
Oct 20, 2011·Human Molecular Genetics·Silvia CorrochanoAbraham Acevedo-Arozena
Oct 16, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yan WangMichael Y Sherman
Mar 29, 2011·Cold Spring Harbor Perspectives in Biology·Steven Finkbeiner
Apr 21, 2012·International Journal of Cell Biology·Trond Lamark, Terje Johansen
Jul 24, 2007·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·A AigelsreiterH Denk
Jun 25, 2013·Molecular Neurobiology·Ying-Tsen TungYung-Feng Liao
May 16, 2014·Acta Biochimica Et Biophysica Sinica·Ting ZhuLifeng Yang
Feb 10, 2009·Rinshō shinkeigaku = Clinical neurology·Nobuyuki Nukina
Jan 27, 2012·Rinshō shinkeigaku = Clinical neurology·Nobuyuki Nukina
Sep 4, 2010·Seminars in Immunopathology·Yoshinobu Ichimura, Masaaki Komatsu
Sep 1, 2005·FEBS Letters·Michael G PaineMarie W Wooten
Mar 10, 2016·Journal of Molecular Biology·Joseph D Mancias, Alec C Kimmelman
Apr 9, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Xiao-Ming YinWentao Gao
Oct 27, 2007·Neuropathology and Applied Neurobiology·E KuusistoI Alafuzoff
Oct 15, 2013·British Journal of Pharmacology·L D Osellame, M R Duchen
Dec 8, 2009·Current Opinion in Cell Biology·Trond Lamark, Terje Johansen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.